Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial

Maria De Santis, Joan Palou Redorta, Hiroyuki Nishiyama, Michał Krawczyński, Artur Seyitkuliev, A. M. Novikov, Félix Guerrero‐Ramos, Р. А. Зуков, Minoru Katō, Takashi Kawahara, Lieven Goeman, Javier Puente, Eva Hellmis, Thomas Powles, Piotr Radziszewski, Kilian M. Gust, P. Vasey, Pierre Bigot, Yves Fradet, Jarmo C. B. Hunting, J. Armstrong, Suliman Boulos, Stephan Hois, Neal D. Shore, Paul Anderson, Daniel Brungs, Ian D. Davis, Amanda Glasgow, Carole A. Harris, Phillip Parente, Manish Patel, P. Vasey, Ian Vela, Robert Zielinski, Johannes W. Buchegger, Kilian M. Gust, W. Horninger, Georg C. Hutterer, Wolfgang Loidl, Ferdinand Luger, Lukas Lusuardi, Renate Pichler, Filip Ameye, Lieven Goeman, Steven Joniau, Thierry Roumeguère, Yves Fradet, Jason Izard, Girish S. Kulkarni, Jean-Benoit Paradis, Fred Saad, Abdel Rahmene Azzouzi, Philippe Barthélémy, Pierre Bigot, Marc Colombel, J. Deturmeny, Thierry Lebrét, G. Robert, Fabien Saint, Delphine Topart, Martin Bögemann, Jozefina Casuscelli, Maria De Santis, Susan Feyerabend, M. Garcia-Schürmann, Gencay Hatiboglu, Axel Hegele, Eva Hellmis, Christian Keil, Jörg Klier, Thomas Pulte, Lars Pursche, Bernd J. Schmitz‐Dräger, Viktoria Schütz, Philipp Spiegelhalder, E. Stagge, Georgi Tosev, Christoph von Klot, Gaku Arai, Kensuke Bekku, Toshiki Etani, Katsuyoshi Hashine, Junichi Inokuchi, Koji Izumi, Kouji Izumi, Toshiyuki Kamoto, Shuya Kandori, Minoru Kato, Takashi Kawahara, Noriyasu Kawai, Eiji Kikuchi, Tomokazu Kimura, Hiroshi Kitamura, Yasuyuki Kobayashi, Yukihiro Kondo, Naoya Masumori, Tomohiro Matsuo, Yasuyoshi Miyata, Ryuichi Mizuno, Shoichiro Mukai